VERA · Vera Therapeutics, Inc.
$31.26
-1.02 (-3.14%)
At close · Aug 20
Market Cap
$2.25B
Shares
72.06M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-08-05 | — | $200,000,000 | — | — | 8-K , filed 2025-08-05 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-02-26 |
| 2024-12-31 | $13,000 | 10-K, filed 2026-02-26 |
| 2023-12-31 | $0 | 10-K, filed 2026-02-26 |
Key facts
CIK
1831828
CUSIP
92337R101
13F (30d)
212 filings
206 filers
Visit website
Investor relations